121 related articles for article (PubMed ID: 9559734)
1. Efficient reactivation of latent herpes simplex virus type 1 infection by excimer laser keratectomy in the experimental rabbit ocular model.
Dhaliwal DK; Barnhorst DA; Romanowski E; Rehkopf PG; Gordon YJ
Am J Ophthalmol; 1998 Apr; 125(4):488-92. PubMed ID: 9559734
[TBL] [Abstract][Full Text] [Related]
2. Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model.
Epstein SP; Fisher EM; Sternberg GJ; Franklin W; Gordon R; Ho JJ; Asbell PA
CLAO J; 2001 Apr; 27(2):94-9. PubMed ID: 11352456
[TBL] [Abstract][Full Text] [Related]
3. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
Asbell PA
Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy.
Dhaliwal DK; Romanowski EG; Yates KA; Barnhorst DA; Goldstein M; Deeter RG; Fish DN; Gordon YJ
Cornea; 1999 Nov; 18(6):693-9. PubMed ID: 10571301
[TBL] [Abstract][Full Text] [Related]
5. Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Goldstein M; Gordon YJ
Am J Ophthalmol; 2001 Apr; 131(4):506-7. PubMed ID: 11292417
[TBL] [Abstract][Full Text] [Related]
6. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
7. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
[TBL] [Abstract][Full Text] [Related]
8. A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model.
Gordon YJ; Romanowski E; Araullo-Cruz T
Invest Ophthalmol Vis Sci; 1990 May; 31(5):921-4. PubMed ID: 2159452
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
[TBL] [Abstract][Full Text] [Related]
10. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
11. Corneal nerves are necessary for adrenergic reactivation of ocular herpes.
Rootman DS; Haruta Y; Hill JM; Kaufman HE
Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):351-6. PubMed ID: 2830200
[TBL] [Abstract][Full Text] [Related]
12. The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models.
Gordon YJ; Yates KA; Mah FS; Romanowski EG
J Ocul Pharmacol Ther; 2003 Jun; 19(3):233-45. PubMed ID: 12828841
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of latent herpes simplex virus by excimer laser photokeratectomy.
Pepose JS; Laycock KA; Miller JK; Chansue E; Lenze EJ; Gans LA; Smith ME
Am J Ophthalmol; 1992 Jul; 114(1):45-50. PubMed ID: 1320329
[TBL] [Abstract][Full Text] [Related]
14. Aerosolization of infectious virus by excimer laser.
Moreira LB; Sanchez D; Trousdale MD; Stevenson D; Yarber F; McDonnell PJ
Am J Ophthalmol; 1997 Mar; 123(3):297-302. PubMed ID: 9063238
[TBL] [Abstract][Full Text] [Related]
15. Morphological response to UV-B irradiation after excimer-laser photorefractive keratectomy.
Nagy ZZ; Hiscott P; Seitz B; Schlötzer-Schrehardt U; Süveges I; Naumann GO
Ger J Ophthalmol; 1996 Nov; 5(6):352-61. PubMed ID: 9479518
[TBL] [Abstract][Full Text] [Related]
16. A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.
Perng GC; Maguen B; Jin L; Mott KR; Osorio N; Slanina SM; Yukht A; Ghiasi H; Nesburn AB; Inman M; Henderson G; Jones C; Wechsler SL
J Virol; 2002 Feb; 76(3):1224-35. PubMed ID: 11773398
[TBL] [Abstract][Full Text] [Related]
17. Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.
BenMohamed L; Osorio N; Srivastava R; Khan AA; Simpson JL; Wechsler SL
J Neurovirol; 2015 Oct; 21(5):508-17. PubMed ID: 26002839
[TBL] [Abstract][Full Text] [Related]
18. Ocular reactivation phenotype of HSV-1 strain F(MP)E, a corticosteroid-sensitive strain.
Marquart M; Bhattacharjee P; Zheng X; Kaufman H; Thompson H; Varnell E; Hill J
Curr Eye Res; 2003; 26(3-4):205-9. PubMed ID: 12815548
[TBL] [Abstract][Full Text] [Related]
19. A study on HSV-1 corneal potential infection by in situ nucleic acid hybridization.
Li S; Xie L; Dong X
Yan Ke Xue Bao; 1995 Sep; 11(3):117-9. PubMed ID: 8758835
[TBL] [Abstract][Full Text] [Related]
20. HSV-1 latent rabbits shed viral DNA into their saliva.
Hill JM; Nolan NM; McFerrin HE; Clement C; Foster TP; Halford WP; Kousoulas KG; Lukiw WJ; Thompson HW; Stern EM; Bhattacharjee PS
Virol J; 2012 Sep; 9():221. PubMed ID: 23021094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
